|
|
Blood, 15 December 2004, Vol. 104, No. 13, pp. 3958-3964.
Prepublished online as a Blood First Edition Paper on August 19, 2004; DOI 10.1182/blood-2004-03-1203.
Previous Article | Next Article 
Submitted March 30, 2004
Accepted July 30, 2004
Patients with severe sepsis vary markedly in their ability to generate activate protein C
Patricia C Y Liaw*, Charles T Esmon, Kamyar Kahnamoui, Shelley Schmidt, Sarah Kahnamoui, Gary Ferrell, Suzanne Beaudin, Jim A Julian, Jeffrey I Weitz, Mark Crowther, Mark Loeb, and Deborah J Cook
Department of Medicine, McMaster University, Hamilton, ON, Canada; Henderson Research Centre, Hamilton, ON, Canada
Department of Biochemistry, McMaster University, Hamilton, ON, Canada
Departments of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
Department of Surgery, McMaster University, Hamilton, ON, Canada
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA
Departments of Pathology, Biochemistry, Molecular Biology, University of Oklahoma Health Sciences Centre, Oklahoma City, OK, USA
Howard Hughes Medical Institute, USA
* Corresponding author; email: pliaw{at}thrombosis.hhscr.org.
Activated protein C (APC) supplementation significantly reduces mortality in patients with severe sepsis, presumably by downregulating coagulation, inflammation, and apoptosis. In vivo, endogenous APC is generated from protein C (PC) "on demand" in response to elevated thrombin levels. Thrombomodulin and EPCR are endothelial receptors required to generate APC endogenously. Since these receptors may be downregulated in sepsis, we measured plasma markers of APC generation in 32 severe sepsis patients to determine whether APC generation is impaired, and whether markers of APC generation correlate with 28-day mortality. Relative to normals, all patients had elevated F1+2 and TAT levels (markers of thrombin generation and inhibition, respectively), and 28/32 patients had reduced PC levels. In 20 patients, APC levels paralleled elevated F1+2 levels, whereas 12 patients had low APC levels despite elevated F1+2 levels, suggesting that APC generation is impaired in the latter. No significant differences exist between survivors and non-survivors with respect to baseline PC levels, F1+2 levels, and APACHE II scores. Baseline APC levels were higher in survivors (p=0.024), and baseline F1+2/APC ratios were lower in survivors (p=0.047). Larger studies are warranted to establish whether APC generation profiles aid in managing sepsis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
APC: braking neutrophils to benefit patients?
- Joseph P. Mizgerd
Blood 2004 104: 3841.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
L. J. Toltl, S. Beaudin, P. C. Liaw, and and the Canadian Critical Care Translational Biolo
Activated Protein C Up-Regulates IL-10 and Inhibits Tissue Factor in Blood Monocytes
J. Immunol.,
August 1, 2008;
181(3):
2165 - 2173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol.,
March 1, 2008;
83(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Ventetuolo and M. M. Levy
Sepsis: A Clinical Update
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
571 - 577.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Borgel, C. Bornstain, P. H. Reitsma, N. Lerolle, S. Gandrille, F. Dali-Ali, C. T. Esmon, J.-Y. Fagon, M. Aiach, and J.-L. Diehl
A Comparative Study of the Protein C Pathway in Septic and Nonseptic Patients with Organ Failure
Am. J. Respir. Crit. Care Med.,
November 1, 2007;
176(9):
878 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Kerschen, J. A. Fernandez, B. C. Cooley, X. V. Yang, R. Sood, L. O. Mosnier, F. J. Castellino, N. Mackman, J. H. Griffin, and H. Weiler
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C
J. Exp. Med.,
October 1, 2007;
204(10):
2439 - 2448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Kowalska, S. A. Mahmud, M. P. Lambert, M. Poncz, and A. Slungaard
Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge
Blood,
September 15, 2007;
110(6):
1903 - 1905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tang, L. Ivanciu, N. Popescu, G. Peer, E. Hack, C. Lupu, F. B. Taylor Jr, and F. Lupu
Sepsis-Induced Coagulation in the Baboon Lung Is Associated with Decreased Tissue Factor Pathway Inhibitor
Am. J. Pathol.,
September 1, 2007;
171(3):
1066 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, J. A. Bastarache, N. Wickersham, X. Fang, M. A. Matthay, and L. B. Ware
Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar Coagulation
Am. J. Respir. Cell Mol. Biol.,
April 1, 2007;
36(4):
497 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Lay, D. Donahue, M.-J. Tsai, and F. J. Castellino
Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency
Blood,
March 1, 2007;
109(5):
1984 - 1991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zheng, W. Li, J.-M. Gu, D. Qu, G. L. Ferrell, N. L. Esmon, and C. T. Esmon
Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice
Blood,
February 1, 2007;
109(3):
1003 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Raivio, J. A. Fernandez, A. Kuitunen, J. H. Griffin, R. Lassila, and J. Petaja
Activation of protein C and hemodynamic recovery after coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg.,
January 1, 2007;
133(1):
44 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Taneja and D. C. Cheng
Con: Heparin-Bonded Cardiopulmonary Bypass Circuits Should Be Routine for All Cardiac Surgical Procedures
Anesth. Analg.,
December 1, 2006;
103(6):
1370 - 1372.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Russell
Management of Sepsis
N. Engl. J. Med.,
October 19, 2006;
355(16):
1699 - 1713.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald
Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells
J. Biol. Chem.,
July 21, 2006;
281(29):
20077 - 20084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yano, P. C. Liaw, J. M. Mullington, S.-C. Shih, H. Okada, N. Bodyak, P. M. Kang, L. Toltl, B. Belikoff, J. Buras, et al.
Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality
J. Exp. Med.,
June 12, 2006;
203(6):
1447 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|